Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Journal of the American Pharmacists Association : Japha|October 22, 2004
Eplerenone: selective aldosterone antagonism in management of cardiovascular and renal diseaseBarbara J Brennan, Nancy E MartinJournal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 16, 2008
Fibrin sealant for retinoblastoma: where are we?Nancy E Martin, Jonathan W Kim, David H AbramsonJournal of Clinical Pharmacology|November 17, 2004
The effect of food on the pharmacokinetics of a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, M100240Iolanda Cirillo, Nancy E Martin, Barbara Brennan, et al.Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|January 24, 2004
Permeation prediction of M100240 using the parallel artificial membrane permeability assayKin-Kai Hwang, Nancy E Martin, Lan Jiang, et al.Journal of Clinical Pharmacology|May 18, 2004
Optimizing dose selection with modeling and simulation: application to the vasopeptidase inhibitor M100240Marc Pfister, Nancy E Martin, Lloyd P Haskell, et al.Kidney International Reports|September 14, 2019
Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney DiseaseSteven Fishbane, Bruce S Spinowitz, Wayne A Wisemandle, et al.Clinical Therapeutics|July 31, 2016
Pharmacokinetic and Pharmacodynamic Equivalence of Epoetin Hospira and Epogen After Single Subcutaneous Doses to Healthy Male SubjectsDennis Stalker, Susan Reid, Atulkumar Ramaiya, et al.Clinical Journal of the American Society of Nephrology : CJASN|June 21, 2018
Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney DiseaseSteven Fishbane, Bhupinder Singh, Seema Kumbhat, et al.American Journal of Therapeutics|September 17, 2003
Mass balance study of [14C]M100240, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy male subjectsBharti Shah, Gary Emmons, Shashank Rohatagi, et al.Journal of Pharmacological and Toxicological Methods|October 21, 2003
Site-specific absorption of M100240 and MDL 100,173 in rats evaluated using Sweetana-Grass diffusion chamber technologyKin-Kai Hwang, Lan Jiang, Ying Ren, et al.Pageof 2